ENVERIC BIOSCIENCES, INC.

ENVB ·Healthcare, Drug Manufacturers - General, United States
Financial Statements Income Statement
Annual Quarterly

Income Statement

Line Item FY2010
Revenue
Cost of Revenue
Gross Profit
Gross Margin
Operating Expenses
Research & Development
SG&A Expense $35.9K
Operating Income $-35.9K
Operating Margin
Interest Expense
Pretax Income $-35.9K
Income Tax Expense $3.6K
Net Income $-39.4K
Net Margin
EPS (Basic) $0.00
EPS (Diluted) $0.00
Shares Outstanding (Basic) 936.0M
Shares Outstanding (Diluted) 936.0M
Dividends Per Share
← Newer Page 3 of 3 Older →